Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isovorin/5-FU vs TS-1 in Advanced Gastric Cancer
NCT00195572Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2002
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of levoleucovorin in gastric cancer (GC), sponsored by Pfizer. Started May 2002; status: completed.
02
Drugs
levoleucovorin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00195572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195572.